Final Visit Completed for Last Patient in Phase 3 Trial Testing Accordion Pill

Final Visit Completed for Last Patient in Phase 3 Trial Testing Accordion Pill
The last Parkinson’s patient in Intec Pharma’s Phase 3 ACCORDANCE clinical trial has completed their final visit, the company announced. Taking place at approximately 90 clinical sites throughout the United States, Europe, and Israel, the trial (NCT02605434) was designed to test the safety and efficacy of the Accordion Pill-Carbidopa/Levodopa (AP-CD/LD) compared with immediate release Sinemet, an approved combination of levodopa ... read more
Source: Parkinson’s News TodayPublished on 2019-05-08By Iqra Mumal